Scholarlink

Background <p>Endovascular therapy (EVT) for aortoiliac (AI) disease has shown favorable outcomes with recent advances in technology. Furthermore, the transradial approach (TRA) has emerged as a less invasive alternative to transfemoral access, improving patient comfort. However, data on CS implantation using the TRA remain limited.</p> Case presentation <p>We report two cases in which a VIABAHN® VBX-CS (W.L. Gore &amp; Associates, Flagstaff, AZ, USA) were successfully deployed for AI disease using the TRA. In both cases, a 6-Fr transradial guiding sheath was used. The CSs were advanced and accurately deployed using a TRA without complications. The completion of the angiography confirmed the proper expansion and positioning of the CS. Both patients were discharged uneventfully without access-site complications.</p> Discussion <p>These cases demonstrate the feasibility and safety of AI balloon-expandable CS implantation using the TRA. The evolution of the device has enabled the delivery of relatively large CS using the TRA, expanding the applicability of this less invasive technique.</p> Conclusion <p>Transradial CS treatment may be a promising procedure for AI lesions, offering both procedural safety and patient comfort.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Deployment of aortoiliac balloon-expandable covered stent via the transradial approach: report of two cases

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年1月26日

查看全文
  • Yasuyuki Tsuchida,
  • Naoki Hayakawa,
  • Toshiki Tsurumaki,
  • Hiromi Miwa,
  • Masanao Inoue,
  • Shinya Ichihara,
  • Shunichi Kushida

摘要

Background

Endovascular therapy (EVT) for aortoiliac (AI) disease has shown favorable outcomes with recent advances in technology. Furthermore, the transradial approach (TRA) has emerged as a less invasive alternative to transfemoral access, improving patient comfort. However, data on CS implantation using the TRA remain limited.

Case presentation

We report two cases in which a VIABAHN® VBX-CS (W.L. Gore & Associates, Flagstaff, AZ, USA) were successfully deployed for AI disease using the TRA. In both cases, a 6-Fr transradial guiding sheath was used. The CSs were advanced and accurately deployed using a TRA without complications. The completion of the angiography confirmed the proper expansion and positioning of the CS. Both patients were discharged uneventfully without access-site complications.

Discussion

These cases demonstrate the feasibility and safety of AI balloon-expandable CS implantation using the TRA. The evolution of the device has enabled the delivery of relatively large CS using the TRA, expanding the applicability of this less invasive technique.

Conclusion

Transradial CS treatment may be a promising procedure for AI lesions, offering both procedural safety and patient comfort.